Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Mitessh Thakkar of miteshthacker.com suggests buying IndusInd Bank and advises selling Hindalco Industries below Rs 186.
In an interview to CNBC-TV18's Surabhi Upadhyay and Nigel D'souza, SP Tulsian shared his readings and outlook on the fundamentals of the market and specific stocks.
Individual news flow along with negative outlook for the sector by Credit Suisse hit the sector. Frontline stocks tank, pulling down the markets further.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Maruti Suzuki and sell HDIL and Aurobindo Pharma.
Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma and feels that Strides Shasun may slip 5-6 percent.
According to Mitessh Thakkar of mitesshthakkar.com, one can sell Capital First, Aurobindo Pharma and Biocon and can buy Bharti Infratel and MRF.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy KRBL and ITD Cementation and sell Aurobindo Pharma..
Sudarshan Sukhani of s2analytics.com is of the view that one can buy India Cements, Century Textiles and Industries and Rural Electrification Corporation and sell Aurobindo Pharma.
Banks, pharma companies and a telecom tower company are on the radar of analysts today.
Sudip Bandhopadhyay, Market Expert is of the view that one can buy DLF, Aurobindo Pharma and Natco Pharma.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Aurobindo Pharma and SAIL and buy Bajaj Auto while he feels that NBFCs are ripe for a major correction.
Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, JK Tyre and Fortis Healthcare.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy HCL Technologies, Bata India, Exide Industries and Union Bank of India and sell Aurobindo Pharma.
From Hindustan Zinc to Cyient and Aurobindo Pharma, a look at what brokerages are talking about these stocks.
Ashwani Gujral of ashwanigujral.com advises selling SBI and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, Canara Bank and City Union Bank.
According to Gaurang Shah of Geojit Financial Services, one may prefer Aurobindo Pharma.
Sudarshan Sukhani of s2analytics.com
According to Sandeep Wagle of powermywealth.com, one may hold Aurobindo Pharma.
Gaurang Shah of Geojit Financial Services is of the view that one may remain invested in Aurobindo Pharma.
Mitessh Thakkar of miteshthacker.com suggests selling Aurobindo Pharma and Sun Pharma.